Remove Compounding Remove Seminar Remove Vaccines
article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

Seminars in Arthritis and Rheumatism. Azurity Pharmaceuticals announces the FDA approval of XIFYRM™ (meloxicam injection) for the management of moderate-to-severe pain in adults. PR Newswire. June 10, 2025. Accessed June 10, 2025. Meloxicam: Selective COX-2 inhibition in clinical practice. December 21, 2004.

FDA 73
article thumbnail

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Monitoring Nutrition Is Crucial in Cardiovascular Disease Management

Pharmacy Times

Whole foods contain a mixture of micronutrients, fiber, antioxidants, and other compounds that augment the absorption and application of essential vitamins and minerals. Coenzyme Q10 for patients with cardiovascular disease: JACC focus seminar. Hypertension is a known risk factor for heart disease, stroke, and heart failure.

article thumbnail

Resident Mental Health Matters

Pharmacy Times

I did not understand what she meant until after I completed my fall seminar. My preceptor said, “[Because] you finished your fall seminar, your goal this weekend is to take a break for a day and to take some time to celebrate your accomplishment.”

article thumbnail

Message from the Chair an Exciting Year

ISPE

In addition, we took the Board on tours of Vetter’s facilities for sterile products and through all the production steps: compounding to fill-finish to automated visual inspection and secondary packaging. Most Board members were able to attend in person, and we had very productive Board and Executive Committee sessions.